Beta Bionics (BBNX) Other Operating Expenses (2024 - 2026)

Beta Bionics' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $20.7 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 54.72% year-over-year to $20.7 million; the TTM figure through Mar 2026 stood at $68.7 million (up 60.51% YoY), while the FY2025 annual figure was $61.4 million, up 65.57% from the prior year.
• Other Operating Expenses came in at $20.7 million for Q1 2026 at Beta Bionics, up from $16.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $20.7 million in Q1 2026 to a low of $7.7 million in Q1 2024.
• A 3-year average of $13.2 million and a median of $13.4 million in 2025 frame the typical range for Other Operating Expenses.
• On a YoY basis, Other Operating Expenses climbed as much as 74.89% in 2025 and fell as far as 51.18% in 2025.
• Beta Bionics' Other Operating Expenses stood at $10.8 million in 2024, then surged by 51.18% to $16.3 million in 2025, then advanced by 26.94% to $20.7 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $20.7 million, $16.3 million, and $16.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison